Month: March 2023

Knoxville, Tennessee, March 17, 2023 (GLOBE NEWSWIRE) — Healthcare Integrated Technologies, Inc. (“HiTC”), a leading innovator of healthcare technology solutions, is proud to announce the approval of U.S. Patent 11,587,423, issued on February 21, 2023. The patent is titled “Fall Validation with Privacy-Aware Monitoring” and was developed by inventors Kenneth M. Greenwood, Scott M. Boruff, and Jurgen K. Vollrath. The patent application, initially filed on July 30, 2021, followed a provisional application filed on August 3, 2020. The patented technology describes a method and system for detecting a person falling, confirming a potential fall, and taking action to mitigate the effects of a fall. The system is designed with privacy in mind, ensuring that sensitive data is protected without compromising the effectiveness...

ATHENS, Greece, March 17, 2023 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with Cargill International S.A., Geneva, for one of its Kamsarmax dry bulk vessels, the m/v Leonidas P. C. The gross charter rate is US$17,000 per day, minus a 4.75% commission paid to third parties, for a period of minimum eleven (11) months to maximum thirteen (13) months. The charter commenced earlier today. The “Leonidas P. C.” is a 82,165 dwt Kamsarmax dry bulk vessel built in 2011. The employment of “Leonidas P. C.” is anticipated to generate approximately US$5.61 million of gross revenue for the minimum scheduled period...

Alvotech to present two posters related to pharmacokinetics and confirmatory clinical studies for AVT04 (ustekinumab), a proposed biosimilar to Stelara® Marketing applications for AVT04 have been submitted in major markets including U.S. and EuropeAlvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the presentation of two posters related to its clinical studies in support of biosimilarity and clinical comparability of Alvotech’s ATV04 (ustekinumab) and the reference product Stelara® at the 2023 American Academy of Dermatology (AAD) Annual Meeting, March 17-21 in New Orleans. Earlier this year, Alvotech announced two regulatory updates for AVT04. In February 2023 Alvotech announced that a Marketing Authorization Application...

Alvotech to present two posters related to pharmacokinetics and confirmatory clinical studies for AVT04 (ustekinumab), a proposed biosimilar to Stelara® Marketing applications for AVT04 have been submitted in major markets including U.S. and EuropeREYKJAVIK, Iceland, March 17, 2023 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the presentation of two posters related to its clinical studies in support of biosimilarity and clinical comparability of Alvotech’s ATV04 (ustekinumab) and the reference product Stelara® at the 2023 American Academy of Dermatology (AAD) Annual Meeting, March 17-21 in New Orleans. Earlier this year, Alvotech announced two regulatory updates for AVT04. In February 2023 Alvotech...

Announcement no. 4 2023 Copenhagen – 17 March 2023 – Agillic A/S (Nasdaq First North Growth Market Denmark: AGILC) – Reporting of transactions in Agillic A/S shares by four persons with managerial responsibilities Agillic A/S has received notification pursuant to Article 19 of the Market Abuse Regulation of transactions related to shares in Agillic A/S made by four persons with managerial responsibilities in Agillic and/or persons closely associated with them. The notification is related to the transaction announced on 14 March 2023 in Company Announcement 02-2023. For further information, please contact:Emre Gürsoy, CEO, Agillic A/S+45 30 78 42 00emre.gursoy@agillic.com Claus Boysen, CFO, Agillic A/S+45 28 49 18 46claus.boysen@agillic.com Certified AdviserJohn Norden, Norden CEF A/S About Agillic A/SAgillic is a Danish software company...